Julie Metcalf

Company: Fusion Pharmaceuticals

Job title: Senior Scientist

Seminars:

EGFRvIII-Targeted Alpha Therapy for Precision Cancer Cell Destruction in GBM 4:00 pm

What is targeted alpha therapy (TAT) and theranostics? Advantages of TAT for treatment of GBM Preclinical evaluation of an EGFRvIII-targeted alpha therapy in PDX models with varying degrees of BBB permeabilityRead more

day: Conference Day 2